Company Description
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
This platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).
It also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.
The company was founded in 2014 and is based in Kirkland, Washington.
| Country | United States |
| Founded | 2014 |
| IPO Date | Mar 6, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 300 |
| CEO | Brian Webster |
Contact Details
Address: 3933 Lake Washington Blvd NE, Suite 200 Kirkland, Washington 98033 United States | |
| Phone | 425 279 8002 |
| Website | kestramedical.com |
Stock Details
| Ticker Symbol | KMTS |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001877184 |
| ISIN Number | BMG524411052 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Brian Webster | President, Chief Executive Officer, and Director |
| Vaseem Mahboob | Chief Financial Officer |
| Traci S. Umberger | General Counsel, Chief Administrative Officer, and Director |
| Phillip D. Foshee, Jr. | Senior Vice President of Research & Development |
| Debra Schotz | Senior Vice President of Marketing |
| Jeffrey Laub | Senior Vice President of Supply Chain Operations |
| Jeffrey Schwartz | Director, Chairman of the Board of Directors |
| Raymond W. Cohen | Director |
| Christopher Gordon | Director |
| Mary Kay Ladone | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | 10-Q | Quarterly Report |
| Apr 14, 2025 | 8-K | Current Report |
| Mar 7, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 7, 2025 | 8-K | Current Report |
| Mar 6, 2025 | 424B4 | Prospectus |
| Mar 6, 2025 | CERT | Certification by an exchange approving securities for listing |
| Mar 6, 2025 | 8-A12B | Registration of securities |
| Mar 5, 2025 | EFFECT | Notice of Effectiveness |
| Mar 5, 2025 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| Mar 3, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |